<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Maury, Philippe</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Radiofrequency Ablation without ICD Effective and Safe for Well-Tolerated SMVT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with structural heart disease (SHD) who experience sustained monomorphic ventricular tachycardia (SMVT) are usually considered to have a poor prognosis. This article discusses the results of the Radio-Frequency Ablation as a primary management for Sustained Monomorphic Ventricular Tachycardia in Patients With Structural Heart Disease (ie, without implantation of a defibrillator). The investigators hypothesized that these patients would have a favorable prognosis and that any recurrences would not result in death.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>